Over the course of 2018, we will be transferring the activities of Cystic Fibrosis Foundation Therapeutics Inc. (CFFT) to the CF Foundation. As our nonprofit drug discovery and development affiliate, CFFT was already controlled by the Foundation. Therefore, this transfer merely reflects a shift in the formal organizational structure to reduce potential confusion by the CF community and simplify administration, enabling us to operate optimally to achieve our mission.

Learn about the cutting-edge research conducted at the Cystic Fibrosis Foundation Therapeutics Lab, dedicated to advancing new therapies for everyone with cystic fibrosis, as well as the extensive range of research that the Foundation supports.